marketcaparena

SOLV

Solventum Corp

Company overview

Market capitalization
$15.24B
Employees
20,584
Latest publication
2026-09-29
About Solventum Corp

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Revenue2,209,000,000USD2,007,000,000USD1,998,000,000USD2,096,000,000USD2,161,000,000USD2,070,000,000USD2,075,000,000USD2,082,000,000USD
Cost Of Revenue922,000,000USD910,000,000USD1,013,000,000USD919,000,000USD986,000,000USD956,000,000USD956,000,000USD917,000,000USD
Gross Profit1,286,000,000USD1,097,000,000USD985,000,000USD1,177,000,000USD1,175,000,000USD1,114,000,000USD1,119,000,000USD1,165,000,000USD
Research Development178,000,000USD189,000,000USD176,000,000USD183,000,000USD189,000,000USD193,000,000USD199,000,000USD189,000,000USD
Selling General Administrative927,000,000USD827,000,000USD759,000,000USD780,000,000USD772,000,000USD769,000,000USD784,000,000USD701,000,000USD
Total Operating Expenses1,105,000,000USD1,016,000,000USD-693,000,000USD1,040,000,000USD961,000,000USD962,000,000USD983,000,000USD890,000,000USD
Operating Income181,000,000USD81,000,000USD1,678,000,000USD137,000,000USD214,000,000USD152,000,000USD136,000,000USD275,000,000USD
Total Other Income Expense Net-73,000,000USD-65,000,000USD-1,620,000,000USD1,377,000,000USD-111,000,000USD-114,000,000USD-123,000,000USD-108,000,000USD
Income Before Tax108,000,000USD16,000,000USD58,000,000USD1,514,000,000USD103,000,000USD38,000,000USD13,000,000USD167,000,000USD
Income Tax Expense15,000,000USD3,000,000USD-5,000,000USD248,000,000USD13,000,000USD-99,000,000USD-17,000,000USD45,000,000USD
Net Income92,000,000USD13,000,000USD63,000,000USD1,266,000,000USD90,000,000USD137,000,000USD31,000,000USD122,000,000USD
Interest Expense—62,000,000USD51,000,000USD89,000,000USD103,000,000USD104,000,000USD107,000,000USD107,000,000USD
Net Interest Income—-62,000,000USD-51,000,000USD-89,000,000USD-103,000,000USD-104,000,000USD-107,000,000USD-107,000,000USD
Tax Provision—3,000,000USD-5,000,000USD248,000,000USD13,000,000USD-99,000,000USD-17,000,000USD45,000,000USD
Net Income From Continuing Ops—13,000,000USD63,000,000USD1,266,000,000USD90,000,000USD137,000,000USD30,000,000USD122,000,000USD
Ebit—78,000,000USD109,000,000USD1,603,000,000USD206,000,000USD142,000,000USD120,000,000USD274,000,000USD
Ebitda—213,000,000USD489,000,000USD1,724,000,000USD328,000,000USD271,000,000USD270,000,000USD407,000,000USD
Depreciation And Amortization—135,000,000USD380,000,000USD121,000,000USD122,000,000USD129,000,000USD150,000,000USD133,000,000USD
Reconciled Depreciation—135,000,000USD117,000,000USD121,000,000USD122,000,000USD129,000,000USD150,000,000USD133,000,000USD
Unclassified Operating Expenses——-1,628,000,000USD77,000,000USD————
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
Total Revenue8,325,000,000USD8,254,000,000USD8,197,000,000USD8,130,000,000USD8,171,000,000USD7,281,000,000USD
Cost Of Revenue3,874,000,000USD3,661,000,000USD3,504,000,000USD3,435,000,000USD3,248,000,000USD2,966,000,000USD
Gross Profit4,451,000,000USD4,593,000,000USD4,693,000,000USD4,695,000,000USD4,923,000,000USD4,315,000,000USD
Research Development739,000,000USD775,000,000USD758,000,000USD767,000,000USD766,000,000USD719,000,000USD
Selling General Administrative3,080,000,000USD2,782,000,000USD2,321,000,000USD2,235,000,000USD2,278,000,000USD2,166,000,000USD
Unclassified Operating Expenses-1,549,000,000USD—-78,000,000USD———
Total Operating Expenses2,270,000,000USD3,557,000,000USD3,001,000,000USD3,002,000,000USD3,044,000,000USD2,885,000,000USD
Operating Income2,181,000,000USD1,036,000,000USD1,692,000,000USD1,693,000,000USD1,879,000,000USD1,430,000,000USD
Interest Expense347,000,000USD367,000,000USD0USD0USD——
Net Interest Income-347,000,000USD-367,000,000USD0USD0USD——
Income Before Tax1,713,000,000USD605,000,000USD1,667,000,000USD1,692,000,000USD1,882,000,000USD1,440,000,000USD
Income Tax Expense157,000,000USD127,000,000USD321,000,000USD349,000,000USD422,000,000USD302,000,000USD
Tax Provision157,000,000USD127,000,000USD218,000,000USD349,000,000USD422,000,000USD302,000,000USD
Net Income1,556,000,000USD479,000,000USD1,346,000,000USD1,343,000,000USD1,460,000,000USD1,138,000,000USD
Net Income From Continuing Ops1,556,000,000USD478,000,000USD692,000,000USD1,343,000,000USD1,460,000,000USD1,138,000,000USD
Ebit2,060,000,000USD972,000,000USD1,667,000,000USD1,692,000,000USD1,882,000,000USD1,430,000,000USD
Ebitda2,549,000,000USD1,527,000,000USD2,228,000,000USD2,270,000,000USD2,479,000,000USD2,029,000,000USD
Depreciation And Amortization489,000,000USD555,000,000USD561,000,000USD578,000,000USD597,000,000USD599,000,000USD
Reconciled Depreciation489,000,000USD555,000,000USD561,000,000USD578,000,000USD597,000,000USD599,000,000USD
Total Other Income Expense Net-468,000,000USD-431,000,000USD-25,000,000USD-1,000,000USD3,000,000USD10,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets14,243,000,000USD14,097,000,000USD14,294,000,000USD13,973,000,000USD15,074,000,000USD14,527,000,000USD14,457,000,000USD14,745,000,000USD
Cash And Equivalents403,000,000USD———————
Total Current Assets3,741,000,000USD3,583,000,000USD3,859,000,000USD4,407,000,000USD3,208,000,000USD3,053,000,000USD3,249,000,000USD3,354,000,000USD
Other Current Assets865,000,000USD874,000,000USD881,000,000USD697,000,000USD499,000,000USD542,000,000USD293,000,000USD524,000,000USD
Other Non Current Assets904,000,000USD———————
Total Liabilities9,443,000,000USD———————
Total Current Liabilities3,663,000,000USD3,346,000,000USD3,136,000,000USD2,938,000,000USD2,620,000,000USD2,566,000,000USD2,703,000,000USD2,904,000,000USD
Other Current Liabilities1,528,000,000USD———————
Other Non Current Liabilities486,000,000USD———————
Total Stockholder Equity4,800,000,000USD4,969,000,000USD5,049,000,000USD4,986,000,000USD3,645,000,000USD3,262,000,000USD2,959,000,000USD3,192,000,000USD
Total Equity Including Noncontrolling Interest4,800,000,000USD———————
Short Long Term Debt0USD505,000,000USD———100,000,000USD200,000,000USD300,000,000USD
Long Term Debt4,573,000,000USD4,575,000,000USD5,035,000,000USD5,137,000,000USD7,815,000,000USD7,813,000,000USD7,810,000,000USD7,809,000,000USD
Deferred Revenue596,000,000USD———————
Net Receivables1,310,000,000USD1,059,000,000USD1,034,000,000USD1,019,000,000USD1,255,000,000USD1,111,000,000USD1,229,000,000USD1,105,000,000USD
Inventory1,040,000,000USD1,089,000,000USD1,066,000,000USD1,049,000,000USD962,000,000USD866,000,000USD965,000,000USD953,000,000USD
Property Plant Equipment Net1,753,000,000USD1,543,000,000USD1,326,000,000USD1,336,000,000USD1,313,000,000USD1,198,000,000USD1,622,000,000USD1,599,000,000USD
Goodwill5,626,000,000USD———————
Intangible Assets2,408,000,000USD2,497,000,000USD2,592,000,000USD2,223,000,000USD2,302,000,000USD2,365,000,000USD2,544,000,000USD2,651,000,000USD
Accounts Payable701,000,000USD699,000,000USD687,000,000USD669,000,000USD643,000,000USD604,000,000USD618,000,000USD560,000,000USD
Short Term Debt506,000,000USD505,000,000USD———100,000,000USD200,000,000USD300,000,000USD
Common Stock2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
Retained Earnings1,902,000,000USD1,810,000,000USD1,797,000,000USD1,734,000,000USD468,000,000USD378,000,000USD242,000,000USD211,000,000USD
Accumulated Other Comprehensive Income-669,000,000USD-670,000,000USD-625,000,000USD-604,000,000USD-631,000,000USD-899,000,000USD-1,056,000,000USD-765,000,000USD
Total Liab—9,128,000,000USD9,245,000,000USD8,987,000,000USD11,429,000,000USD11,265,000,000USD11,498,000,000USD11,553,000,000USD
Other Current Liab—1,529,000,000USD1,828,000,000USD1,693,000,000USD1,303,000,000USD1,164,000,000USD1,191,000,000USD1,481,000,000USD
Capital Stock—2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
Good Will—5,626,000,000USD5,704,000,000USD5,260,000,000USD5,274,000,000USD4,991,000,000USD6,377,000,000USD6,592,000,000USD
Cash—561,000,000USD878,000,000USD1,642,000,000USD492,000,000USD534,000,000USD762,000,000USD772,000,000USD
Cash And Short Term Investments—561,000,000USD878,000,000USD1,642,000,000USD492,000,000USD534,000,000USD762,000,000USD772,000,000USD
Current Deferred Revenue—613,000,000USD621,000,000USD576,000,000USD557,000,000USD558,000,000USD572,000,000USD563,000,000USD
Net Debt—4,519,000,000USD4,157,000,000USD3,495,000,000USD7,323,000,000USD7,379,000,000USD7,248,000,000USD7,337,000,000USD
Short Long Term Debt Total—5,080,000,000USD5,035,000,000USD5,137,000,000USD7,815,000,000USD7,913,000,000USD8,010,000,000USD8,109,000,000USD
Property Plant Equipment Gross—3,598,000,000USD3,193,000,000USD3,179,000,000USD3,044,000,000USD2,864,000,000USD3,610,000,000USD3,597,000,000USD
Common Stock Shares Outstanding—175,500,000shares175,300,000shares175,400,000shares175,200,000shares174,800,000shares174,500,000shares173,900,000shares
Non Current Assets Total—10,514,000,000USD10,435,000,000USD9,566,000,000USD11,866,000,000USD11,474,000,000USD11,208,000,000USD11,391,000,000USD
Non Current Liabilities Total—5,782,000,000USD6,109,000,000USD6,049,000,000USD8,809,000,000USD8,699,000,000USD8,795,000,000USD8,649,000,000USD
Non Current Liabilities Other—478,000,000USD546,000,000USD437,000,000USD371,000,000USD279,000,000USD410,000,000USD305,000,000USD
Non Currrent Assets Other—848,000,000USD813,000,000USD747,000,000USD2,977,000,000USD2,917,000,000USD665,000,000USD549,000,000USD
Net Working Capital—237,000,000USD723,000,000USD1,469,000,000USD588,000,000USD487,000,000USD546,000,000USD450,000,000USD
Unclassified Current Liabilities—-505,000,000USD——117,000,000USD40,000,000USD-78,000,000USD-300,000,000USD
Unclassified Non Current Liabilities—729,000,000USD528,000,000USD475,000,000USD623,000,000USD607,000,000USD575,000,000USD535,000,000USD
Unclassified Equity—3,825,000,000USD3,873,000,000USD3,852,000,000USD3,804,000,000USD3,779,000,000USD3,769,000,000USD3,742,000,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
Total Assets14,294,000,000USD14,457,000,000USD13,943,000,000USD13,594,000,000USD14,075,000,000USD—
Intangible Assets2,592,000,000USD2,544,000,000USD2,902,000,000USD3,252,000,000USD3,661,000,000USD—
Other Current Assets881,000,000USD293,000,000USD155,000,000USD126,000,000USD108,000,000USD—
Total Liab9,245,000,000USD11,498,000,000USD2,277,000,000USD1,852,000,000USD2,016,000,000USD—
Total Stockholder Equity5,049,000,000USD2,959,000,000USD11,666,000,000USD11,742,000,000USD12,059,000,000USD—
Other Current Liab1,828,000,000USD1,191,000,000USD571,000,000USD377,000,000USD1,057,000,000USD—
Common Stock2,000,000USD2,000,000USD2,000,000USD12,239,000,000USD12,259,000,000USD—
Capital Stock2,000,000USD2,000,000USD2,000,000USD———
Retained Earnings1,797,000,000USD242,000,000USD0USD———
Good Will5,704,000,000USD6,377,000,000USD6,535,000,000USD6,434,000,000USD6,666,000,000USD—
Cash878,000,000USD762,000,000USD194,000,000USD61,000,000USD91,000,000USD—
Cash And Short Term Investments878,000,000USD762,000,000USD194,000,000USD61,000,000USD91,000,000USD—
Total Current Assets3,859,000,000USD3,249,000,000USD2,519,000,000USD2,231,000,000USD2,189,000,000USD—
Total Current Liabilities3,136,000,000USD2,703,000,000USD1,728,000,000USD1,311,000,000USD1,406,000,000USD—
Current Deferred Revenue621,000,000USD572,000,000USD574,000,000USD559,000,000USD574,000,000USD—
Net Debt4,157,000,000USD7,248,000,000USD8,109,000,000USD34,000,000USD21,000,000USD—
Short Long Term Debt Total5,035,000,000USD8,010,000,000USD8,303,000,000USD95,000,000USD112,000,000USD—
Long Term Debt5,035,000,000USD7,810,000,000USD8,303,000,000USD———
Net Receivables1,034,000,000USD1,229,000,000USD1,313,000,000USD1,171,000,000USD1,177,000,000USD—
Inventory1,066,000,000USD965,000,000USD857,000,000USD873,000,000USD813,000,000USD—
Accounts Payable687,000,000USD618,000,000USD477,000,000USD348,000,000USD320,000,000USD—
Property Plant Equipment Net1,326,000,000USD1,622,000,000USD1,457,000,000USD1,319,000,000USD1,306,000,000USD—
Property Plant Equipment Gross3,193,000,000USD3,610,000,000USD3,338,000,000USD3,090,000,000USD2,980,000,000USD—
Accumulated Other Comprehensive Income-625,000,000USD-1,056,000,000USD-337,000,000USD-497,000,000USD-200,000,000USD—
Common Stock Shares Outstanding175,300,000shares173,700,000shares172,709,505shares172,466,022shares172,466,022shares172,466,022shares
Non Current Assets Total10,435,000,000USD11,208,000,000USD11,424,000,000USD11,363,000,000USD11,886,000,000USD—
Non Current Liabilities Total6,109,000,000USD8,795,000,000USD549,000,000USD541,000,000USD610,000,000USD—
Non Current Liabilities Other546,000,000USD410,000,000USD224,000,000USD235,000,000USD245,000,000USD—
Non Currrent Assets Other813,000,000USD665,000,000USD530,000,000USD358,000,000USD253,000,000USD—
Net Working Capital723,000,000USD546,000,000USD1,145,000,000USD920,000,000USD783,000,000USD—
Unclassified Non Current Liabilities528,000,000USD575,000,000USD-7,978,000,000USD306,000,000USD365,000,000USD—
Unclassified Equity3,873,000,000USD3,769,000,000USD11,999,000,000USD———
Short Term Debt—200,000,000USD29,000,000USD27,000,000USD29,000,000USD—
Short Long Term Debt—200,000,000USD————
Unclassified Current Liabilities—-78,000,000USD77,000,000USD—-574,000,000USD—
Short Term Investments——406,000,000USD———
Unclassified Current Assets——-406,000,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation268,000,000USD
Stock Based Compensation89,000,000USD
Deferred Income Tax-88,000,000USD
Change To Account Receivables-286,000,000USD
Change To Inventory18,000,000USD
Change To Liabilities26,000,000USD
Change In Working Capital-242,000,000USD
Operating Cash Flow38,000,000USD
Capital Expenditures-167,000,000USD
Other Investing Activities-3,000,000USD
Unclassified Investing Cash Flow6,000,000USD
Investing Cash Flow-164,000,000USD
Net Debt Issuance0USD
Net Common Stock Issuance-355,000,000USD
Other Financing Activities-44,000,000USD
Unclassified Financing Cash Flow49,000,000USD
Financing Cash Flow-350,000,000USD
Effect Of Forex Changes On Cash1,000,000USD
Change In Cash-475,000,000USD
End Cash Flow403,000,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income13,000,000USD63,000,000USD1,266,000,000USD90,000,000USD137,000,000USD31,000,000USD122,000,000USD89,000,000USD
Depreciation135,000,000USD117,000,000USD121,000,000USD122,000,000USD129,000,000USD150,000,000USD133,000,000USD133,000,000USD
Stock Based Compensation51,000,000USD37,000,000USD41,000,000USD34,000,000USD49,000,000USD25,000,000USD27,000,000USD56,000,000USD
Other Non Cash Items13,000,000USD-43,000,000USD-1,587,000,000USD17,000,000USD15,000,000USD4,000,000USD11,000,000USD10,000,000USD
Change To Account Receivables-6,000,000USD5,000,000USD84,000,000USD-22,000,000USD11,000,000USD62,000,000USD13,000,000USD123,000,000USD
Change To Inventory-32,000,000USD-5,000,000USD-57,000,000USD-45,000,000USD-32,000,000USD-33,000,000USD-42,000,000USD-5,000,000USD
Change In Working Capital-360,000,000USD-6,000,000USD105,000,000USD-61,000,000USD-157,000,000USD71,000,000USD-87,000,000USD98,000,000USD
Total Cash From Operating Activities-189,000,000USD95,000,000USD76,000,000USD169,000,000USD29,000,000USD219,000,000USD169,000,000USD355,000,000USD
Capital Expenditures-84,000,000USD-63,000,000USD-97,000,000USD-110,000,000USD-109,000,000USD-127,000,000USD-93,000,000USD-58,000,000USD
Free Cash Flow-273,000,000USD32,000,000USD-21,000,000USD59,000,000USD-80,000,000USD92,000,000USD76,000,000USD297,000,000USD
Total Cashflows From Investing Activities-77,000,000USD-745,000,000USD3,766,000,000USD-110,000,000USD-114,000,000USD-127,000,000USD-93,000,000USD-58,000,000USD
Net Borrowings46,000,000USD-100,000,000USD-2,770,000,000USD-100,000,000USD-100,000,000USD-100,000,000USD-200,000,000USD—
Total Cash From Financing Activities-50,000,000USD-115,000,000USD-2,693,000,000USD-110,000,000USD-139,000,000USD-104,000,000USD-202,000,000USD-396,000,000USD
Sale Purchase Of Stock-67,000,000USD———0USD———
Change In Cash-317,000,000USD-764,000,000USD1,150,000,000USD-42,000,000USD-228,000,000USD-10,000,000USD-125,000,000USD-99,000,000USD
Begin Period Cash Flow878,000,000USD1,642,000,000USD492,000,000USD534,000,000USD762,000,000USD772,000,000USD897,000,000USD996,000,000USD
End Period Cash Flow561,000,000USD878,000,000USD1,642,000,000USD492,000,000USD534,000,000USD762,000,000USD772,000,000USD897,000,000USD
Other Cashflows From Investing Activities7,000,000USD-6,000,000USD3,863,000,000USD—-5,000,000USD———
Other Cashflows From Financing Activities-29,000,000USD-15,000,000USD77,000,000USD-10,000,000USD-39,000,000USD-4,000,000USD-2,000,000USD-396,000,000USD
Unclassified Operating Cash Flow-41,000,000USD-73,000,000USD130,000,000USD-33,000,000USD-144,000,000USD-62,000,000USD-37,000,000USD-31,000,000USD
Unclassified Investing Cash Flow—-676,000,000USD-3,766,000,000USD110,000,000USD114,000,000USD127,000,000USD93,000,000USD58,000,000USD
Investments——3,766,000,000USD-110,000,000USD-114,000,000USD-127,000,000USD-93,000,000USD-58,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
Net Income1,556,000,000USD479,000,000USD1,346,000,000USD1,343,000,000USD1,460,000,000USD1,138,000,000USD
Depreciation489,000,000USD555,000,000USD561,000,000USD578,000,000USD597,000,000USD599,000,000USD
Stock Based Compensation161,000,000USD112,000,000USD39,000,000USD37,000,000USD38,000,000USD35,000,000USD
Other Non Cash Items-1,598,000,000USD34,000,000USD-15,000,000USD64,000,000USD74,000,000USD74,000,000USD
Change To Account Receivables78,000,000USD276,000,000USD-129,000,000USD-32,000,000USD-1,000,000USD41,000,000USD
Change To Inventory-139,000,000USD-132,000,000USD23,000,000USD-82,000,000USD-136,000,000USD43,000,000USD
Change In Working Capital-119,000,000USD160,000,000USD126,000,000USD-202,000,000USD67,000,000USD234,000,000USD
Total Cash From Operating Activities369,000,000USD1,185,000,000USD1,915,000,000USD1,679,000,000USD2,202,000,000USD2,026,000,000USD
Capital Expenditures-379,000,000USD-380,000,000USD-290,000,000USD-251,000,000USD-277,000,000USD-271,000,000USD
Free Cash Flow-10,000,000USD805,000,000USD1,625,000,000USD1,428,000,000USD1,925,000,000USD1,755,000,000USD
Total Cashflows From Investing Activities2,797,000,000USD-380,000,000USD-230,000,000USD-253,000,000USD-278,000,000USD228,000,000USD
Net Borrowings-3,070,000,000USD8,003,000,000USD0USD0USD——
Total Cash From Financing Activities-3,057,000,000USD-240,000,000USD-1,552,000,000USD-1,460,000,000USD-1,960,000,000USD-2,211,000,000USD
Change In Cash116,000,000USD568,000,000USD133,000,000USD-30,000,000USD-33,000,000USD40,000,000USD
Begin Period Cash Flow762,000,000USD194,000,000USD61,000,000USD91,000,000USD124,000,000USD84,000,000USD
End Period Cash Flow878,000,000USD762,000,000USD194,000,000USD61,000,000USD91,000,000USD124,000,000USD
Other Cashflows From Investing Activities3,872,000,000USD——-2,000,000USD-1,000,000USD30,000,000USD
Other Cashflows From Financing Activities13,000,000USD-8,243,000,000USD-1,552,000,000USD-1,460,000,000USD-1,960,000,000USD-1,766,000,000USD
Unclassified Operating Cash Flow-120,000,000USD-155,000,000USD-142,000,000USD-141,000,000USD-34,000,000USD-54,000,000USD
Unclassified Investing Cash Flow-696,000,000USD380,000,000USD290,000,000USD253,000,000USD278,000,000USD241,000,000USD
Investments—-380,000,000USD-230,000,000USD-253,000,000USD-278,000,000USD228,000,000USD
Unclassified Financing Cash Flow—————-445,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30ProductCost Of Software And Rentals511,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductProduct1,698,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentDental Solutions396,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentHealth Information Systems354,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentMed Surg1,372,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentPurification And Filtration0USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductCost Of Software And Rentals493,000,000USD0001964738-26-000024
Q1 2026Quarterly · 2026-03-31ProductProduct1,513,000,000USD0001964738-26-000024
Q1 2026Quarterly · 2026-03-31SegmentDental Solutions354,000,000USD0001964738-26-000024
Q1 2026Quarterly · 2026-03-31SegmentHealth Information Systems342,000,000USD0001964738-26-000024
Q1 2026Quarterly · 2026-03-31SegmentMed Surg1,234,000,000USD0001964738-26-000024
Q1 2026Quarterly · 2026-03-31SegmentPurification And Filtration0USD0001964738-26-000024
Q4 2025Quarterly · 2025-12-31ProductCost Of Software And Rentals508,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductProduct1,490,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentDental Solutions343,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentHealth Information Systems347,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentMed Surg1,236,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentOther135,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentPurification And Filtration0USDLegacy provider
FY 2025Yearly · 2025-12-31GeographyInternational3,657,000,000USD0001964738-26-000007
FY 2025Yearly · 2025-12-31GeographyUnited States4,668,000,000USD0001964738-26-000007
FY 2025Yearly · 2025-12-31ProductCost Of Software And Rentals1,976,000,000USD0001964738-26-000007
FY 2025Yearly · 2025-12-31ProductProduct6,349,000,000USD0001964738-26-000007
FY 2025Yearly · 2025-12-31SegmentDental Solutions1,349,000,000USD0001964738-26-000007
FY 2025Yearly · 2025-12-31SegmentHealth Information Systems1,360,000,000USD0001964738-26-000007
FY 2025Yearly · 2025-12-31SegmentMed Surg4,817,000,000USD0001964738-26-000007
FY 2025Yearly · 2025-12-31SegmentOther302,000,000USD0001964738-26-000007
FY 2025Yearly · 2025-12-31SegmentPurification And Filtration497,000,000USD0001964738-26-000007
Q3 2025Quarterly · 2025-09-30ProductCost Of Software And Rentals502,000,000USD0001964738-25-000091
Q3 2025Quarterly · 2025-09-30ProductProduct1,594,000,000USD0001964738-25-000091
Q3 2025Quarterly · 2025-09-30SegmentDental Solutions340,000,000USD0001964738-25-000091
Q3 2025Quarterly · 2025-09-30SegmentHealth Information Systems345,000,000USD0001964738-25-000091
Q3 2025Quarterly · 2025-09-30SegmentMed Surg1,206,000,000USD0001964738-25-000091
Q3 2025Quarterly · 2025-09-30SegmentOther77,000,000USD0001964738-25-000091
Q3 2025Quarterly · 2025-09-30SegmentPurification And Filtration128,000,000USD0001964738-25-000091
Q2 2025Quarterly · 2025-06-30ProductCost Of Software And Rentals493,000,000USD0001964738-25-000064
Q2 2025Quarterly · 2025-06-30ProductProduct1,668,000,000USD0001964738-25-000064
Q2 2025Quarterly · 2025-06-30SegmentDental Solutions338,000,000USD0001964738-25-000064
Q2 2025Quarterly · 2025-06-30SegmentHealth Information Systems339,000,000USD0001964738-25-000064
Q2 2025Quarterly · 2025-06-30SegmentMed Surg1,218,000,000USD0001964738-25-000064
Q2 2025Quarterly · 2025-06-30SegmentOther14,000,000USD0001964738-25-000064
Q2 2025Quarterly · 2025-06-30SegmentPurification And Filtration252,000,000USD0001964738-25-000064
Q1 2025Quarterly · 2025-03-31ProductCost Of Software And Rentals473,000,000USD0001964738-26-000024
Q1 2025Quarterly · 2025-03-31ProductProduct1,597,000,000USD0001964738-26-000024
Q1 2025Quarterly · 2025-03-31SegmentDental Solutions328,000,000USD0001964738-26-000024
Q1 2025Quarterly · 2025-03-31SegmentHealth Information Systems329,000,000USD0001964738-26-000024
Q1 2025Quarterly · 2025-03-31SegmentMed Surg1,157,000,000USD0001964738-26-000024
Q1 2025Quarterly · 2025-03-31SegmentOther76,000,000USD0001964738-26-000024
Q1 2025Quarterly · 2025-03-31SegmentPurification And Filtration180,000,000USD0001964738-26-000024
Q4 2024Quarterly · 2024-12-31ProductCost Of Software And Rentals493,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductProduct1,582,000,000USDLegacy provider
FY 2024Yearly · 2024-12-31GeographyInternational3,695,000,000USD0001964738-26-000007
FY 2024Yearly · 2024-12-31GeographyUnited States4,559,000,000USD0001964738-26-000007
FY 2024Yearly · 2024-12-31ProductCost Of Software And Rentals1,906,000,000USD0001964738-26-000007
FY 2024Yearly · 2024-12-31ProductProduct6,348,000,000USD0001964738-26-000007
FY 2024Yearly · 2024-12-31SegmentDental Solutions1,295,000,000USD0001964738-26-000007
FY 2024Yearly · 2024-12-31SegmentHealth Information Systems1,306,000,000USD0001964738-26-000007
FY 2024Yearly · 2024-12-31SegmentMed Surg4,637,000,000USD0001964738-26-000007
FY 2024Yearly · 2024-12-31SegmentOther307,000,000USD0001964738-26-000007
FY 2024Yearly · 2024-12-31SegmentPurification And Filtration709,000,000USD0001964738-26-000007
Q3 2024Quarterly · 2024-09-30ProductCost Of Software And Rentals474,000,000USD0001964738-25-000091
Q3 2024Quarterly · 2024-09-30ProductProduct1,608,000,000USD0001964738-25-000091
Q3 2024Quarterly · 2024-09-30SegmentDental Solutions313,000,000USD0001964738-25-000091
Q3 2024Quarterly · 2024-09-30SegmentHealth Information Systems326,000,000USD0001964738-25-000091
Q3 2024Quarterly · 2024-09-30SegmentMed Surg1,182,000,000USD0001964738-25-000091
Q3 2024Quarterly · 2024-09-30SegmentOther81,000,000USD0001964738-25-000091
Q3 2024Quarterly · 2024-09-30SegmentPurification And Filtration180,000,000USD0001964738-25-000091
Q2 2024Quarterly · 2024-06-30SegmentDental Solutions331,000,000USD0001964738-25-000064
Q2 2024Quarterly · 2024-06-30SegmentHealth Information Systems328,000,000USD0001964738-25-000064
Q2 2024Quarterly · 2024-06-30SegmentMed Surg1,162,000,000USD0001964738-25-000064
Q2 2024Quarterly · 2024-06-30SegmentOther22,000,000USD0001964738-25-000064
Q2 2024Quarterly · 2024-06-30SegmentPurification And Filtration238,000,000USD0001964738-25-000064
FY 2023Yearly · 2023-12-31GeographyInternational3,726,000,000USD0001964738-26-000007
FY 2023Yearly · 2023-12-31GeographyUnited States4,471,000,000USD0001964738-26-000007
FY 2023Yearly · 2023-12-31ProductCost Of Software And Rentals1,901,000,000USD0001964738-26-000007
FY 2023Yearly · 2023-12-31ProductProduct6,296,000,000USD0001964738-26-000007
FY 2023Yearly · 2023-12-31SegmentDental Solutions1,329,000,000USD0001964738-26-000007
FY 2023Yearly · 2023-12-31SegmentHealth Information Systems1,285,000,000USD0001964738-26-000007
FY 2023Yearly · 2023-12-31SegmentMed Surg4,632,000,000USD0001964738-26-000007
FY 2023Yearly · 2023-12-31SegmentOther262,000,000USD0001964738-26-000007
FY 2023Yearly · 2023-12-31SegmentPurification And Filtration689,000,000USD0001964738-26-000007
FY 2022Yearly · 2022-12-31GeographyInternational3,680,000,000USD0001964738-25-000019
FY 2022Yearly · 2022-12-31GeographyUnited States4,450,000,000USD0001964738-25-000019
FY 2022Yearly · 2022-12-31ProductCost Of Software And Rentals1,830,000,000USD0001964738-25-000019
FY 2022Yearly · 2022-12-31ProductProduct6,300,000,000USD0001964738-25-000019
FY 2022Yearly · 2022-12-31SegmentDental Solutions1,327,000,000USD0001964738-25-000019
FY 2022Yearly · 2022-12-31SegmentHealth Information Systems1,227,000,000USD0001964738-25-000019
FY 2022Yearly · 2022-12-31SegmentMed Surg4,585,000,000USD0001964738-25-000019
FY 2022Yearly · 2022-12-31SegmentPurification And Filtration991,000,000USD0001964738-25-000019

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.